Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
11:25:41 28/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 43.30 USD | -3.91% |
|
-2.93% | -54.69% |
| Market Cap | 6.53TCr 5.86TCr 5.42TCr 4.91TCr 9.17TCr 6,21900Cr 9.28TCr 65TCr 26TCr 3,25500Cr 25TCr 24TCr 10,33200Cr | P/E 2026 * |
17.1x | P/E 2027 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.17TCr 6.43TCr 5.95TCr 5.39TCr 10TCr 6,83000Cr 10TCr 71TCr 28TCr 3,57400Cr 27TCr 26TCr 11,34600Cr | EV / Sales 2026 * |
3.39x | EV / Sales 2027 * | 3.2x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed |
Last Transcript: Boston Scientific Corporation
| 1 day | -3.94% | ||
| 1 week | -2.59% | ||
| Current month | -0.68% | ||
| 1 month | -1.71% | ||
| 3 months | -5.87% | ||
| 6 months | -25.83% | ||
| Current year | -54.53% |
| 1 week | 39.57 |  | 46.16 |
| 1 month | 39.57 | | 46.16 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 105.65 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.88% | -2.59% | -57.06% | -13.38% | 6.53TCr | |
| +1.66% | +1.55% | +26.38% | +62.35% | 26TCr | |
| +1.21% | +0.49% | +8.35% | +26.96% | 16TCr | |
| +0.41% | +4.60% | -17.89% | +73.24% | 15TCr | |
| +0.83% | +3.54% | +11.36% | +46.77% | 5.23TCr | |
| +1.72% | +2.11% | -12.83% | -6.95% | 5.19TCr | |
| +1.09% | -1.41% | +8.47% | +66.09% | 5.08TCr | |
| +2.05% | +2.00% | +24.31% | +79.20% | 5TCr | |
| +1.77% | +4.74% | +38.51% | +102.43% | 4.6TCr | |
| +3.29% | +2.55% | +196.58% | +168.90% | 4.22TCr | |
| Average | +0.97% | +1.99% | +22.62% | +60.56% | 9.33TCr | |
| Weighted average by Cap. | +0.97% | +1.80% | +14.23% | +55.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.11TCr 1.9TCr 1.75TCr 1.59TCr 2.97TCr 2,01200Cr 3TCr 21TCr 8.35TCr 1,05300Cr 7.93TCr 7.76TCr 3,34200Cr | 2.21TCr 1.99TCr 1.84TCr 1.66TCr 3.11TCr 2,10800Cr 3.14TCr 22TCr 8.74TCr 1,10300Cr 8.31TCr 8.13TCr 3,50200Cr |
| Net income | 375.3Cr 336.72Cr 311.31Cr 281.95Cr 526.75Cr 36TCr 533.12Cr 3.72TCr 1.48TCr 19TCr 1.41TCr 1.38TCr 59TCr | 367.57Cr 329.78Cr 304.9Cr 276.14Cr 515.89Cr 35TCr 522.13Cr 3.65TCr 1.45TCr 18TCr 1.38TCr 1.35TCr 58TCr |
| Net Debt | 641.02Cr 575.13Cr 531.73Cr 481.57Cr 899.69Cr 61TCr 910.57Cr 6.36TCr 2.53TCr 32TCr 2.41TCr 2.35TCr 1,01400Cr | 549.48Cr 493Cr 455.8Cr 412.8Cr 771.22Cr 52TCr 780.54Cr 5.45TCr 2.17TCr 27TCr 2.06TCr 2.02TCr 87TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $43.19 | -4.16% | 3,94,41,794 |
| 27/26/27 | $45.06 | -1.14% | 1,51,39,721 |
| 26/26/26 | $45.58 | -0.24% | 1,19,28,715 |
| 23/26/23 | $45.69 | -0.70% | 87,72,772 |
| 22/26/22 | $46.01 | +3.37% | 1,63,95,574 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
